Loading...

Becton, Dickinson and Company

BDXANYSE
Healthcare
Medical - Instruments & Supplies
$59.24
$-1.36(-2.24%)

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.3/100

Key Financials

Market Cap48.7B
P/E Ratio35.73
EPS (TTM)$2.76
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BDXA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDXA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.73 and a market capitalization of 48.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;